Travatan Z (travoprost) NDC 0078-0946

NDC codes

FDA NDC Directory

Product NDC (as listed)0078-0946Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00078-0946Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0078-0946-40	00078094640	1 BOTTLE in 1 CARTON (0078-0946-40) / 2.5 mL in 1 BOTTLEMarketed from Sep 4, 2020

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Travatan Z
Generic name (nonproprietary): travoprost
Active ingredients: Travoprost — .04 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Novartis Pharmaceuticals Corporation
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021994
Marketing start: Oct 20, 2006
Marketing end: Oct 31, 2026
Other FDA classes: Prostaglandins (Chemical structure)
Identifiers: Product ID 0078-0946_a415f951-2153-4513-959e-2498229ef71fSPL ID a415f951-2153-4513-959e-2498229ef71fSPL set ID 028455e0-ae77-4213-8819-3b58ef7d6a14RxCUI 284008, 285032UNII WJ68R08KX9
Pharmacologic class: Prostaglandin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400078094640 followed by a unit qualifier and the quantity

Package 00078-0946-40. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 27, 2023.

Indications (excerpt from the label)

TRAVATAN Z ® (travoprost ophthalmic solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. TRAVATAN Z is a prostaglandin analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021994

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021994
Product	Strength	Form · route	Labeler	Product NDC
Travatan Ztravoprost	Travoprost .04 mg/mL	Solution/ dropsOphthalmic	Sandoz Inc	66758-095